Wednesday Jul 16
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results
ARIAD Pharmaceuticals, Inc. today announced that it will report its second quarter 2014 financial results on Wednesday, August 6, 2014, before the market opens.
Ariad Pharmaceuticals Sees Large Growth in Short Interest
Ariad Pharmaceuticals was the recipient of a large growth in short interest during the month of June.
Ariad Pharmaceuticals, Inc. Announces Continuation Of Iclusig Review...
CAMBRIDGE, Mass. & LAUSANNE, Switzerland-- --ARIAD Pharmaceuticals, Inc. today announced that the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has provided the Company with a request for limited additional information regarding IclusigA as part of its ongoing review under the Article 20 referral procedure.
Customer Interaction Solutions
Ariad Pharmaceuticals Inc Files (8-K) Disclosing Change in Directors...
ARIAD PHARMACEUTICALS INC FILES Disclosing Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.